Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001641172-25-011555·Aspire Biopharma Holdings, Inc.
Schedule 13G ownership disclosure
ASPIRE BIOPHARMA HLDGS INC
Common Stock · CUSIP: 738920107
Event date: 2025-05-06
- Filing-level shares
- 2,207,886.00
- Percent of class
- 4.52%
- Lance Friedman
Shares: 2,207,886.00 · Class: 4.52%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001641172-25-011555
- Form type
- SCHEDULE 13G/A
- Filer
- Aspire Biopharma Holdings, Inc.
- CIK
- CIK 1847345
- Filed
- May 19, 2025
- Reporting period
- May 06, 2025
- Description
- Schedule 13G beneficial ownership